Listen to this Moment

Based on this Mammologix Moment

Welcome to Mammologix Moments Reads, where we break down insights that matter to your breast imaging practice.

In today's episode, we explore the recent reorganization within the U.S. Food and Drug Administration (FDA) that began on October 1, 2024, and its implications for the Mammography Quality Standards Act (MQSA) Program. This restructuring aims to streamline decision-making and enhance oversight of radiation-emitting products, including mammography machines.

We'll discuss how these changes are designed to improve patient outcomes by strengthening regulatory proce ...